Haemonetics (HAE)
(Delayed Data from NYSE)
$91.42 USD
-0.16 (-0.18%)
Updated Jul 24, 2024 04:00 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
HAE 91.42 -0.16(-0.18%)
Will HAE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HAE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HAE
Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise
Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View
HAE: What are Zacks experts saying now?
Zacks Private Portfolio Services
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
HAE vs. BSX: Which Stock Is the Better Value Option?
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
Other News for HAE
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
AMD initiated, Paramount downgraded: Wall Street's top analyst calls